Abel Hall LLC’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$338K Sell
2,575
-47
-2% -$6.01K 0.06% 389
2026
Q2
$497K Buy
2,622
+5
+0.2% +$742 0.09% 245
2026
Q1
$244K Sell
2,617
-12
-0.5% -$1.06K 0.05% 510
2025
Q4
$211K Buy
+2,629
New +$220K 0.05% 514

Other funds holding ACLS

Abel Hall LLC's ACLS Position: Q3 2026 in Review

Abel Hall LLC reduced its Axcelis (ACLS) stake by 1.8% in Q3 2026, selling an estimated $6.01K and leaving 2,575 shares worth $338K. The position accounts for 0.06% of the portfolio, ranked #389.

Abel Hall LLC first reported a position in ACLS in Q4 2025 and has held it in 4 quarters since. The position peaked at $497K in Q2 2026. 109 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

  • Abel Hall LLC held 2,575 shares of Axcelis worth $338K as of Q3 2026.
  • Abel Hall LLC sold 47 Axcelis shares in Q3 2026, an estimated $6.01K.
  • Axcelis made up 0.06% of Abel Hall LLC's portfolio in Q3 2026, its #389 holding.
  • Abel Hall LLC first reported a position in Axcelis in Q4 2025 and has held it in 4 quarters since.
  • Abel Hall LLC's Axcelis position peaked at $497K in Q2 2026.
  • 109 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.